ascopubs.org

Use of IsoPSA with prostate MRI PIRADS score in biopsy decision making in patients with elevated PSA.

A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer. Predicted probability of csPCa at biopsy.
ascopubs.org

The risk of prostate cancer diagnosis in men with an elevated PSA but low IsoPSA.

Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer. Test results of patients ...
Business Wire

Cleveland Diagnostics Announces Favorable Medicare Local Coverage Determination and Assignment of a CPT-PLA Code for IsoPSA ®

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today two ...
FiercePharma

Cleveland Diagnostics re-ups prostate-specific antigen test push in 'A PSA on PSA'

In tandem with September’s Prostate Cancer Awareness Month, Cleveland Diagnostics is kicking off a campaign to boost awareness of and education around screening tests for the disease. The flagship ...
Business Wire

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA ® Test

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, ...